ArticleCancer reports (Hoboken, N.J.)2022

Targeting radiation-induced upstream stimulatory factor-1 by histone deacetylase inhibitors to reverse radioresistance in prostate cancer.

Seema Gupta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.